Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Dive
preface
classgrid-row grid-gap
Dive
classgrid-col-8

Dr. Gerald V. Quinnan, Jr., received his bachelor's degree in chemistry from the College of Holy Cross (Massachusetts) in 1969 and graduated cum laude from St. Louis University Medical School in 1973. He completed an internship and residency in internal medicine and a fellowship in adult infectious disease at Boston University Medical Center from 1973 to 1977.

Dr. Quinnan became a commissioned officer in the Public Health Service in 1977 and was assigned to the Division of Virology in the Food and Drug Administration's (FDA) Bureau of Biologics (formerly the National Institutes of Health [NIH] Division of Biologics Standards [DBS]). 

In 1980, Dr. Quinnan was appointed Director director of the Herpes Virus Branch of the Division of Virology. From 1980 to 1981 he was also the Acting Deputy Division Director. Dracting deputy division director. Quinnan then became the Director director of the Division of Virology in 1981.

Dive
classgrid-col-4

a black and white photo of a man in a shirt and tie

Span
classcaption

Scan of photo printed in FDA Today around 1990

Span
classcredit

FDA History Office

...

In 1987, biologics was reorganized and renamed the FDA Center for Biologics Research and Evaluation (CBER). Dr. Quinnan was named Deputy Director deputy director of CBER in 1988, and from 1990 to 1992 he was Acting acting CBER Directordirector. Beginning in 1993, Dr. Quinnan was a Professor professor of Preventive Medicine preventive medicine at the Uniformed Services University of the Health Sciences and a consultant for NIH and various other companies and organizations.

He Quinnan is an expert in the immunology and pathogenesis of viral diseases with an emphasis on cell-mediated immunity; , herpes viruses; , retroviruses; , HIV; , and vaccine safety.  As with so many others featured in the biographies section, Dr. Quinnan also led crucial work pursued by Bureau and Center CBER scientists , such as much of the effort in efforts addressing the AIDS epidemic—particularly epidemic, particularly with possible vaccines, ; a robust herpes virus research program, ; and the first license issued to a genetically engineered vaccine (for hepatitis B).

...